Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker CTXR
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 4, 2026 | CTXR Citius Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 26, 2026 | CTXR Citius Pharmaceuticals, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Aug 21, 2026 | CTXR Citius Pharmaceuticals, Inc. | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| Aug 14, 2026 | CTXR Citius Pharmaceuticals, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Aug 5, 2026 | CTXR Citius Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 1, 2026 | CTXR Citius Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| May 15, 2026 | CTXR Citius Pharmaceuticals, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| May 8, 2026 | CTXR Citius Pharmaceuticals, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Apr 29, 2026 | CTXR Citius Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Apr 29, 2026 | CTXR Citius Pharmaceuticals, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Apr 24, 2026 | CTXR Citius Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Apr 24, 2026 | CTXR Citius Pharmaceuticals, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Apr 6, 2026 | CTXR Citius Pharmaceuticals, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Mar 31, 2026 | CTXR Citius Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Mar 10, 2026 | CTXR Citius Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Mar 4, 2026 | CTXR Citius Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Feb 13, 2026 | CTXR Citius Pharmaceuticals, Inc. | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| Feb 13, 2026 | CTXR Citius Pharmaceuticals, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Dec 23, 2025 | CTXR Citius Pharmaceuticals, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Dec 1, 2025 | CTXR Citius Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 1, 2025 | CTXR Citius Pharmaceuticals, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Oct 23, 2025 | CTXR Citius Pharmaceuticals, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Oct 21, 2025 | CTXR Citius Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 21, 2025 | CTXR Citius Pharmaceuticals, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Aug 12, 2025 | CTXR Citius Pharmaceuticals, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jul 8, 2025 | CTXR Citius Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 12, 2025 | CTXR Citius Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 12, 2025 | CTXR Citius Pharmaceuticals, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jun 9, 2025 | CTXR Citius Pharmaceuticals, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Jun 9, 2025 | CTXR Citius Pharmaceuticals, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Jun 9, 2025 | CTXR Citius Pharmaceuticals, Inc. | 3.03 Material Modification to Rights of Security Holders | 8-K | 8-K ↗ |
| Jun 3, 2025 | CTXR Citius Pharmaceuticals, Inc. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Jun 3, 2025 | CTXR Citius Pharmaceuticals, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| May 30, 2025 | CTXR Citius Pharmaceuticals, Inc. | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| May 14, 2025 | CTXR Citius Pharmaceuticals, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 18, 2025 | CTXR Citius Pharmaceuticals, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Apr 18, 2025 | CTXR Citius Pharmaceuticals, Inc. | 3.03 Material Modification to Rights of Security Holders | 8-K | 8-K ↗ |
| Apr 18, 2025 | CTXR Citius Pharmaceuticals, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Apr 18, 2025 | CTXR Citius Pharmaceuticals, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Apr 3, 2025 | CTXR Citius Pharmaceuticals, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Apr 2, 2025 | CTXR Citius Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Apr 2, 2025 | CTXR Citius Pharmaceuticals, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Mar 10, 2025 | CTXR Citius Pharmaceuticals, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Feb 14, 2025 | CTXR Citius Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Feb 6, 2025 | CTXR Citius Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jan 8, 2025 | CTXR Citius Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jan 8, 2025 | CTXR Citius Pharmaceuticals, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jan 7, 2025 | CTXR Citius Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 27, 2024 | CTXR Citius Pharmaceuticals, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Dec 20, 2024 | CTXR Citius Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 16, 2026, 11:11 AM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances